These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34797426)

  • 1. Comparative lipid profiling of murine and human atherosclerotic plaques using high-resolution MALDI MSI.
    Khamehgir-Silz P; Gerbig S; Volk N; Schulz S; Spengler B; Hecker M; Wagner AH
    Pflugers Arch; 2022 Feb; 474(2):231-242. PubMed ID: 34797426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atheroma-Specific Lipids in
    Cao J; Goossens P; Martin-Lorenzo M; Dewez F; Claes BSR; Biessen EAL; Heeren RMA; Balluff B
    J Am Soc Mass Spectrom; 2020 Sep; 31(9):1825-1832. PubMed ID: 32872786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesions.
    Zaima N; Sasaki T; Tanaka H; Cheng XW; Onoue K; Hayasaka T; Goto-Inoue N; Enomoto H; Unno N; Kuzuya M; Setou M
    Atherosclerosis; 2011 Aug; 217(2):427-32. PubMed ID: 21514591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A; Gustafsson R; Kalamajski S; Krams R; Segers D; Rauch U; Roos G; Nilsson J; Oldberg Å; Hultgårdh-Nilsson A
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial Metabolomics Identifies LPC(18:0) and LPA(18:1) in Advanced Atheroma With Translation to Plasma for Cardiovascular Risk Estimation.
    Cao J; Martin-Lorenzo M; van Kuijk K; Wieland EB; Gijbels MJ; Claes BSR; Heredero A; Aldamiz-Echevarria G; Heeren RMA; Goossens P; Sluimer JC; Balluff B; Alvarez-Llamas G
    Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):741-754. PubMed ID: 38299357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo isotopically labeled atherosclerotic aorta plaques in ApoE KO mice and molecular profiling by matrix-assisted laser desorption/ionization mass spectrometric imaging.
    Castro-Perez J; Hatcher N; Kofi Karikari N; Wang SP; Mendoza V; Shion H; Millar A; Shockcor J; Towers M; McLaren D; Shah V; Previs S; Akinsanya K; Cleary M; Roddy TP; Johns DG
    Rapid Commun Mass Spectrom; 2014 Nov; 28(22):2471-9. PubMed ID: 25303476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound Biomicroscopic Imaging for Interleukin-1 Receptor Antagonist-Inhibiting Atherosclerosis and Markers of Inflammation in Atherosclerotic Development in Apolipoprotein-E Knockout Mice.
    Li RJ; Sun Y; Wang Q; Yang J; Yang Y; Song L; Wang Z; Luo XH; Su RJ
    Tex Heart Inst J; 2015 Aug; 42(4):319-26. PubMed ID: 26413013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect and mechanism of recombinant hirudin on atherosclerotic plaques in apolipoprotein E knockout (ApoE(-/-)) mice].
    Tian JF; Ge CJ; Lu SZ; Yuan F; Zhao K
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Feb; 35(2):198-203. PubMed ID: 25881466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
    Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
    Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
    Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
    Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Spectrometry Imaging as a Tool to Investigate Region Specific Lipid Alterations in Symptomatic Human Carotid Atherosclerotic Plaques.
    Greco F; Quercioli L; Pucci A; Rocchiccioli S; Ferrari M; Recchia FA; McDonnell LA
    Metabolites; 2021 Apr; 11(4):. PubMed ID: 33919525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE
    Li D; Chen A; Lan T; Zou Y; Zhao L; Yang P; Qu H; Wei L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    FASEB J; 2019 Mar; 33(3):3437-3450. PubMed ID: 30462530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolic trapping in mouse arteries: nonradioactive assay of atherosclerotic plaque inflammation applicable to drug discovery.
    Conway RG; Chernet E; De Rosa DC; Benschop RJ; Need AB; Collins EC; Bean JS; Kalbfleisch JM; Rekhter MD
    PLoS One; 2012; 7(11):e50349. PubMed ID: 23209718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-atherosclerotic effects of pravastatin in brachiocephalic artery in comparison with en face aorta and aortic roots in ApoE/LDLR
    Kostogrys RB; Franczyk-Zarow M; Gasior-Glogowska M; Kus E; Jasztal A; Wrobel TP; Baranska M; Czyzynska-Cichon I; Drahun A; Manterys A; Chlopicki S
    Pharmacol Rep; 2017 Feb; 69(1):112-118. PubMed ID: 27915184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice.
    Pulakazhi Venu VK; Uboldi P; Dhyani A; Patrini A; Baetta R; Ferri N; Corsini A; Muro AF; Catapano AL; Norata GD
    Thromb Haemost; 2015 Jul; 114(1):186-97. PubMed ID: 25881051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying lipid traces of atherogenic mechanisms in human carotid plaque.
    Slijkhuis N; Towers M; Mirzaian M; Korteland SA; Heijs B; van Gaalen K; Nieuwenhuizen I; Nigg A; van der Heiden K; de Rijke YB; van der Lugt A; Sijbrands EJG; Claude E; van Soest G
    Atherosclerosis; 2023 Nov; 385():117340. PubMed ID: 37913561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.